Over the last 90 days, previous to the date of this filing, there have been 14 insider transactions reported to the SEC for Vertex Pharmaceuticals. These transactions came from the activities of 4 different insiders that resulted in no change to insider holdings with acquisitions exactly offset by dispositions of company shares. Relative to the preceding 90-day window of time, there were 35 transactions from 15 insiders which resulted in the net disposition of 486 shares.
This level of insider transactions is less than the peer group average in the 324-company Bio Therapeutic Drugs peer group over the last 90-day period. Activity in the peer group averaged 38.0 transactions per company, with company insiders acquiring on average 15,943 shares.
SEC Story Link http://www.sec.gov/Archives/edgar/data/875320/000120919119052177/xslF345X03/doc4.xml
|European Equity Benchmarks Close Higher; Eurozone Ec...|
|Sonos Set to Keep Making 'Premium' Products With Ris...|
|Street Color: Baker Hughes Rig Count|
|General Dynamics' 2019, and Q4 Estimates Reduced but...|
|GoDaddy's 2019, 2020, and Q4 Earnings Estimates Scal...|